Trial intelligence / Profile preview

Comparison of vaginal versus sublingual misoprostol for cervical ripening before operative/diagnostic hysteroscopy in premenopausal women

IRCT201012272576N3Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
May 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of misoprostol in None (3 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Primary cervical ripening efficacy. Started May 2010; status: completed.

02

Drugs

misoprostol

Beyond the preview

Go deeper on IRCT201012272576N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201012272576N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call